Abbott Laboratories has reached a proposed settlement that will see civil penalties paid under the US False Claims Act.
News
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
(Updates with DOJ's response in the fifth and sixth paragraphs.) Abbott Laboratories (ABT) will n
Abbott Laboratories (ABT) will not face criminal charges after the US Department of Justice closed a
Some prosecutors believed they had enough to charge Abbott Laboratories, but senior officials opted for civil settlement.
The medical device maker posts fiscal fourth-quarter earnings and revenue that narrowly beat analysts’ estimates.
Investors weigh softer WATCHMAN and urology demand against a still-active device pipeline and capital deployment moves, today, May 27, 2026.